Startseite UR
Einträge von Piendl, Gerhard auf dem Publikationsserver
 | Eine Stufe nach oben |
Anzahl der Einträge: 8.
2025
Goerg, Alina, Piendl, Gerhard, Albert, Veruschka, Ortmann, Olaf 
, Wege, Anja Kathrin und Brockhoff, Gero
(2025)
Mdm2 targeting via PROteolysis TArgeting Chimeras (PROTAC) is efficient in p53 wildtype, p53-mutated, and abemaciclib-resistant estrogen receptor-positive cell lines and superior to mdm2 inhibition.
BMC Cancer 25 (1).
2024
Albert, Veruschka, Bruss, Christina, Tümen, Deniz, Piendl, Gerhard, Weber, Florian , Dahl, Edgar, Seitz, Stephan, Ortmann, Olaf , Wege, Anja K. und Brockhoff, Gero
(2024)
HER4 Affects Sensitivity to Tamoxifen and Abemaciclib in Luminal Breast Cancer Cells and Restricts Tumor Growth in MCF-7-Based Humanized Tumor Mice.
International Journal of Molecular Sciences 25 (13), S. 7475.
2022
Albert, Veruschka, Piendl, Gerhard, Yousseff, Dali, Lammert, Hedwig, Hummel, Michael, Ortmann, Olaf , Jagla, Wolfgang, Gaumann, Andreas, Wege, Anja K. und Brockhoff, Gero
(2022)
Protein kinase C targeting of luminal (T-47D), luminal/HER2-positive (BT474), and triple negative (HCC1806) breast cancer cells in-vitro with AEB071 (Sotrastaurin) is efficient but mediated by subtype specific molecular effects.
Archives of Gynecology and Obstetrics.
2021
Schulz, Daniela, Wetzel, Martin, Eichberger, Jonas, Piendl, Gerhard, Brockhoff, Gero , Wege, Anja K. , Reichert, Torsten, Ettl, Tobias und Bauer, Richard J.
(2021)
Differential Expression of PD-L1 during Cell Cycle Progression of Head and Neck Squamous Cell Carcinoma.
International Journal of Molecular Sciences 22 (23), S. 1-18.
2020
Wege, Anja K., Kirchhammer, Nicole, Kazandjian, Linda Veronique, Prassl, Sandra, Brandt, Michael, Piendl, Gerhard, Ortmann, Olaf , Fischer, Stephan und Brockhoff, Gero
(2020)
A novel rabbit derived anti-HER2 antibody with pronounced therapeutic effectiveness on HER2-positive breast cancer cells in vitro and in humanized tumor mice (HTM).
Journal of Translational Medicine 18, S. 316.
Fiedler, Mathias, Schulz, Daniela , Piendl, Gerhard, Brockhoff, Gero , Eichberger, Jonas, Menevse, Ayse N., Beckhove, Philipp , Hautmann, Matthias G. , Reichert, Torsten E., Ettl, Tobias und Bauer, Richard J.
(2020)
Buparlisib modulates PD-L1 expression in head and neck squamous cell carcinoma cell lines.
Experimental Cell Research 396 (1), S. 112259.
Volltext nicht vorhanden.
, Piendl, Gerhard, Brockhoff, Gero , Eichberger, Jonas, Menevse, Ayse N., Beckhove, Philipp , Hautmann, Matthias G. , Reichert, Torsten E., Ettl, Tobias und Bauer, Richard J.
(2020)
Buparlisib modulates PD-L1 expression in head and neck squamous cell carcinoma cell lines.
Experimental Cell Research 396 (1), S. 112259.
Volltext nicht vorhanden.
2019
Schulz, Daniela , Streller, Melanie, Piendl, Gerhard, Brockhoff, Gero , Reichert, Torsten E., Menevse, Ayse N., Beckhove, Philipp , Hautmann, Matthias G. , Bauer, Richard J. und Ettl, Tobias
(2019)
Differential localization of PD-L1 and Akt-1 involvement in radioresistant and radiosensitive cell lines of head and neck squamous cell carcinoma.
Carcinogenesis 41 (7), S. 984-992.
Volltext nicht vorhanden.
, Streller, Melanie, Piendl, Gerhard, Brockhoff, Gero , Reichert, Torsten E., Menevse, Ayse N., Beckhove, Philipp , Hautmann, Matthias G. , Bauer, Richard J. und Ettl, Tobias
(2019)
Differential localization of PD-L1 and Akt-1 involvement in radioresistant and radiosensitive cell lines of head and neck squamous cell carcinoma.
Carcinogenesis 41 (7), S. 984-992.
Volltext nicht vorhanden.
2007
Treeck, Oliver, Pfeiler, Georg, Mitter, Diana , Lattrich, Claus, Piendl, Gerhard und Ortmann, Olaf
(2007)
Estrogen receptor β1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells.
Journal of Endocrinology 193 (3), S. 421-433.
Volltext nicht vorhanden.
, Lattrich, Claus, Piendl, Gerhard und Ortmann, Olaf
(2007)
Estrogen receptor β1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells.
Journal of Endocrinology 193 (3), S. 421-433.
Volltext nicht vorhanden.
Universitätsbibliothek
Publikationsserver
Kontakt:
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707